Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-18 Sale |
2025-03-20 4:32 pm |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
10,203 | $0.599 | $6,112 | 120,594 (Direct) |
View |
2024-08-20 Sale |
2024-08-22 6:00 pm |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
4,181 | $1.2291 | $5,139 | 130,797 (Direct) |
View |
2024-03-19 Sale |
2024-03-21 4:41 pm |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
5,268 | $2.0855 | $10,986 | 117,728 (Direct) |
View |
2023-12-20 Sale |
2023-12-22 4:11 pm |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
4,077 | $1.3807 | $5,629 | 97,996 (Direct) |
View |
2023-09-22 Sale |
2023-09-22 7:12 pm |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
5,486 | $1.3006 | $7,135 | 80,609 (Direct) |
View |
2023-03-16 Sale |
2023-03-20 6:43 pm |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
2,037 | $1.979 | $4,031 | 71,095 (Direct) |
View |
2022-07-20 Sale |
2022-07-21 4:10 pm |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
5,602 | $1.4223 | $7,968 | 43,689 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-08-20 Exercise |
2024-08-22 6:00 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
11,250 | $0 | 130,797 (Direct) |
View |
2024-01-18 Option Award |
2024-01-19 8:43 pm |
N/A 2034-01-17 |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
200,000 | $0 | 297,996 (Direct) |
View |
2023-12-17 Exercise |
2023-12-19 7:55 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
11,250 | $0 | 113,323 (Direct) |
View |
2023-09-20 Option Award |
2023-09-22 7:12 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
15,000 | $0 | 80,609 (Direct) |
View |
2023-02-02 Option Award |
2023-02-06 4:48 pm |
N/A 2033-02-01 |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
175,000 | $0 | 223,132 (Direct) |
View |
2022-08-10 Option Award |
2022-08-12 4:58 pm |
N/A 2032-08-09 |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
157,500 | $0 | 157,500 (Direct) |
View |
2022-07-19 Option Award |
2022-07-21 4:10 pm |
N/A N/A |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
15,000 | $0 | 43,689 (Direct) |
View |
2022-02-02 Option Award |
2022-02-04 4:52 pm |
N/A 2032-02-01 |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
157,500 | $0 | 169,291 (Direct) |
View |
2021-10-24 Option Award |
2021-10-26 4:29 pm |
N/A 2031-10-23 |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
70,000 | $0 | 70,000 (Direct) |
View |
2021-02-26 Option Award |
2021-03-02 4:59 pm |
N/A 2031-02-25 |
CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel |
125,000 | $0 | 125,000 (Direct) |
View |